Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Diagnosing PCOS in teenagers is challenging and should use strict criteria to avoid misdiagnosis and unnecessary worry.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Hair loss needs more research for better treatments.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Skin development in mammals is controlled by key proteins and signals from underlying cells, involving stem cells for maintenance and repair.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Some common medications can harm male fertility, but many effects can be reversed.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

SHBG may be a useful early indicator and treatment target for PCOS.